PTH is increased as a result of (1) the MR (mineralocorticoid receptor)-mediated calciuretic and magnesiuretic effects, with a trend for hypocalcemia and hypomagnesemia; the resulting secondary hyperparathyroidism causes myocardial fibrosis and disturbed bone metabolism. Here, NR3C2 is linked to secondary hyperparathyroidism.